Lipids derived from the mevalonate pathway in HL-60 cells modulate the interactions of beta 2 integrins with their ligands.
Hill
M E
ME
Yamanouchi Research Institute, Littlemore Park, Oxford.
Daniels
R H
RH
Elmore
M A
MA
Finnen
M J
MJ
D018821:CD18 Antigens / Q000502:physiology*; D002448:Cell Adhesion / Q000187:drug effects; D002454:Cell Differentiation; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000502:physiology*; D005340:Fibrinogen / Q000378:metabolism*; D018922:HL-60 Cells / Q000378:metabolism*; D006801:Humans; D007375:Interleukin-1 / Q000378:metabolism* / Q000494:pharmacology; D008024:Ligands; D016177:Macrophage-1 Antigen / Q000502:physiology; D008798:Mevalonic Acid / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology*; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D014471:Umbilical Veins
D018821:CD18 Antigens; D007375:Interleukin-1; D008024:Ligands; D016177:Macrophage-1 Antigen; D014409:Tumor Necrosis Factor-alpha; D009240:N-Formylmethionine Leucyl-Phenylalanine; D005340:Fibrinogen; D008798:Mevalonic Acid